Editor2026-08-13T12:57:22+00:00Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte FusionⓇEditor2026-08-13T12:57:22+00:00August 13, 2026|
Editor2026-08-13T08:46:16+00:00Pathologic Characterization of Non-Mass Enhancement Lesions of the Breast in MRI-guided BiopsyEditor2026-08-13T08:46:16+00:00August 13, 2026|
Editor2026-08-13T07:30:43+00:00OnePath Diagnostic Now Runs on elea’s AI-Native Pathology Operating SystemEditor2026-08-13T07:30:43+00:00August 13, 2026|
Editor2026-08-12T08:47:23+00:00A multisite survey on patient perspectives of breast cancer risk assessment and supplemental breast cancer screening toolsEditor2026-08-12T08:47:23+00:00August 12, 2026|
Editor2026-08-10T07:51:40+00:00Keeping Digital Pathology Open: The Regulatory Framework Behind Concentriq AP-DxEditor2026-08-10T07:51:40+00:00August 12, 2026|
Editor2026-08-11T14:54:03+00:00Lumea Climbs the 2026 Inc. 5000 Ranking, Reflecting Continued Rapid GrowthEditor2026-08-11T14:54:03+00:00August 11, 2026|
Editor2026-08-11T13:08:19+00:00Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control SoftwareEditor2026-08-11T13:08:19+00:00August 11, 2026|
Reviews
There are no reviews yet.